FULLWELL CROSS MED. CTR. — All Prescriptions & Medications — Page 12
Practice Code: F86010 | ILFORD, IG6 2HG
Showing results 551-600 of 605
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 13 | 171 | £70 | +316.0% ▲ | |
| 13 | 28 | £1.4K | +153.3% ▲ | |
| 13 | 140 | £220 | -50.1% ▼ | |
| 13 | 110 | £204 | -11.0% ▼ | |
| 13 | 2,040 | £1.4K | +16.9% ▲ | |
| 13 | 540 | £950 | -20.4% ▼ | |
| Sodium picosulfate | 12 | 480 | £773 | +243.9% ▲ |
| Eletriptan | 12 | 204 | £727 | +21.5% ▲ |
| Almotriptan | 12 | 72 | £153 | -3.2% ▼ |
| Cabergoline | 12 | 2,640 | £8.0K | +117.3% ▲ |
| Orphenadrine hydrochloride | 12 | 5,400 | £5.0K | +4.0% ▲ |
| Mebendazole | 12 | 188 | £16 | +4.8% ▲ |
| Estradiol valerate | 12 | 868 | £72 | -38.6% ▼ |
| Methotrexate | 12 | 48 | £716 | -59.8% ▼ |
| Ergocalciferol | 12 | 992 | £382 | -28.3% ▼ |
| Other compound vitamin/mineral formulation preparations | 12 | 750 | £112 | -62.6% ▼ |
| Glycopyrronium bromide | 12 | 115 | £184 | -49.6% ▼ |
| 12 | 480 | £44 | -12.2% ▼ | |
| 12 | 2,300 | £302 | -32.4% ▼ | |
| 12 | 1,200 | £3.7K | +10.3% ▲ | |
| 12 | 420 | £1.9K | -46.2% ▼ | |
| Rabeprazole sodium | 11 | 616 | £67 | -78.7% ▼ |
| Sodium cromoglicate | 11 | 3,696 | £5.5K | +6.4% ▲ |
| Perindopril arginine | 11 | 570 | £113 | -7.0% ▼ |
| Aclidinium bromide/formoterol | 11 | 22 | £679 | -68.7% ▼ |
| Levomepromazine hydrochloride | 11 | 110 | £210 | -52.2% ▼ |
| Rifaximin | 11 | 154 | £714 | -59.0% ▼ |
| Oestrogens conjugated with progestogen | 11 | 1,092 | £422 | +54.4% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 11 | 37.0K | £682 | -71.2% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 11 | 20.5K | £314 | -52.0% ▼ |
| Fusidic acid | 11 | 55 | £182 | +6.5% ▲ |
| Timolol and brimonidine | 11 | 60 | £148 | -21.6% ▼ |
| Acetazolamide | 11 | 784 | £30 | -49.2% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 11 | 11 | £139 | +1.3% vs avg |
| Fluocinolone acetonide | 11 | 380 | £63 | +1.0% vs avg |
| Lidocaine hydrochloride | 11 | 1,585 | £424 | -93.6% ▼ |
| 11 | 195 | £554 | -48.0% ▼ | |
| 11 | 245 | £662 | -70.4% ▼ | |
| 11 | 400 | £546 | -66.2% ▼ | |
| 11 | 11 | £44 | -78.6% ▼ | |
| 11 | 410 | £1.8K | -6.4% ▼ | |
| Propantheline bromide | 10 | 1,098 | £935 | -23.0% ▼ |
| Linaclotide | 10 | 420 | £535 | -45.3% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 10 | 308 | £177 | -36.8% ▼ |
| RtS extensively hydrolysed formula, high energy (0913103) | 10 | 169.8K | £4.3K | +74.7% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 10 | 426.5K | £13.9K | +12.5% ▲ |
| Choline salicylate | 10 | 270 | £65 | +126.1% ▲ |
| Clindamycin/tretinoin | 10 | 300 | £114 | -14.8% ▼ |
| Adapalene | 10 | 495 | £172 | -54.3% ▼ |
| 10 | 135 | £347 | -74.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.